Latest Breaking News On - Company or statera biopharma - Page 8 : comparemela.com

Statera BioPharma, Inc : Statera Biopharma Receives Anticipated Notice of Additional Filing Delinquency from Nasdaq

FORT COLLINS, CO / ACCESSWIRE / August 25, 2022 / Statera Biopharma, Inc. (NASDAQ:STAB) (the "Company" or "Statera Biopharma"), a biopharmaceutical company creating next-generation immune therapies that

United statesRussian federationStatera biopharmaCleveland biolabsCompany or statera biopharmaExchange commissionCompany annual report on formEuropean unionNasdaq stock marketCytocom incStatera biopharma incListing qualifications staffNasdaq listing ruleAnnual report

Statera Biopharma Receives Anticipated Notice of Additional Filing Delinquency from Nasdaq

Statera Biopharma Receives Anticipated Notice of Additional Filing Delinquency from Nasdaq
newjerseytelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newjerseytelegraph.com Daily Mail and Mail on Sunday newspapers.

United statesRussian federationStatera biopharmaCleveland biolabsCompany or statera biopharmaExchange commissionCompany annual report on formEuropean unionNasdaq stock marketCytocom incStatera biopharma incStatera biopharmaListing qualifications staffNasdaq listing ruleRisk factorAnnual report

Statera Biopharma Receives Anticipated Notice of Additional Filing Delinquency from Nasdaq

Statera Biopharma Receives Anticipated Notice of Additional Filing Delinquency from Nasdaq
tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.

Statera Biopharma Announces Closing of $5 7 Million Underwritten Public Offering

Statera Biopharma Announces Closing of $5 7 Million Underwritten Public Offering
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesNichol ochsnerStatera biopharmaMilazzo feilBridgeway capital partnersCompany or statera biopharmaExchange commissionCorporate communicationsSyndicate departmentCytocom incStatera biopharma incCommon stockOne year warrantsFive year warrantsYear warrants

Statera Biopharma Announces Closing of $2 0 Million

FORT COLLINS, Colo., Feb. 09, 2022 (GLOBE NEWSWIRE) Statera Biopharma, Inc. (NASDAQ: STAB) (the “Company” or “Statera Biopharma”), a leading.

New yorkUnited statesNichol ochsnerStatera biopharmaMilazzo feilCompany phaseCompany or statera biopharmaExchange commissionCorporate communicationsSyndicate departmentCytocom incStatera biopharma incBenchmark investmentsCapital partnersNasdaq stabStatera biopharma